DRUGS FOR NEGLECTED DISEASES INITIATIVE FONDATION
- Country
- Switzerland
- Type
- Beneficiary
- Website
- www.dndi.org
- Grants received
- 7
Funding record
- 7 grants on record
- €4,497,872.50 awarded in total
- 2009–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
1 further grant is on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- FUNDACAO OSWALDO CRUZ
- FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA
- INSTITUT NATIONAL DE RECHERCHE BIOMEDICALE DU ZAIRE
- INSTITUUT VOOR TROPISCHE GENEESKUNDE
- LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
- SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT
- UNIVERSITATSKLINIKUM BONN
- UNIVERSITY OF BUEA
Calls from this organisation
No published calls from this organisation.
Grants received
- Enhancing the Risk Stratification of Severe Arboviral diseases using host-response Biomarkers in Brazil.
- Stop transmission of gambiense human African trypanosomiasis
- Enabling the WHO-Roadmap 2030
- ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC
- Collaboration for innovation: Establishment of a pan-nematode drug development platform
- Care Package for Treatment and Control of Visceral Leishmaniasis in East Africa
- Development of a DNA vaccine for visceral leishmaniasis
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.